Last reviewed · How we verify

NCT06606600

Impacts of Kebbi Robot Intervention for Older Adults With Mild Dementia

Recruiting now NA Last updated 28 May 2025
What this trial tests

NA trial testing Intensive Kebbi robot interventions in Mild Cognitive Impairment (MCI) in 136 participants. Currently enrolling.

Timeline
3 February 2025
Primary endpoint
30 July 2025
30 July 2025

Quick facts

Lead sponsorNational Tainan Junior College of Nursing
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposesupportive care
Enrollment136
Start date3 February 2025
Primary completion30 July 2025
Estimated completion30 July 2025
Sites2 locations across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

National Tainan Junior College of Nursing

Who can join

65 and older, any sex, with Mild Cognitive Impairment (MCI). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to examine the immediate and sustained effects of an intensive Kebbi robot intervention on cognitive functions, heart rate variability (HRV), and psychological changes for older adults with mild dementia in long-term care (LTC). The main questions it aims to answer are: * Are intensive Kebbi robot interventions effective in improving cognitive functions, HRV, and psychological changes for older adults with mild dementia in LTC? * What are the participants\' experiences and perceptions after intensive Kebbi robot interventions? Researchers will compare intensive Kebbi robot interventions to a control group (receiving usual activity) to see if they are effective in improving cognitive functions, HRV, and psychological changes in older adults with mild dementia in LTC. Participants will: * Participants in the intensive Kebbi robot interventions will receive 30 minutes, thrice weekly, for 12 weeks. Participants in the control group will receive the usual activity. * The outcome measures will be conducted at three time points: before the intervention (T0), immediately after the end of the intervention (T1), and one month after the end of the intervention (T2). * Outcome measurements include the cognitive outcomes: Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Finger Tapping Test (FTT); heart rate variability (HRV); psychological changes: the Geriatric depression scale-short form (GDS-SF), the UCLA Loneliness Scale Version 3 (UCLA- Version 3), and the Friendship scale.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Mild Cognitive Impairment (MCI)

Currently open trials in the same condition.

Other National Tainan Junior College of Nursing trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06606600.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing